Plain-English translation of NCT05558007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called — a gel you apply topically — to help restore erectile function in men who have had their prostate removed due to cancer. Prostate removal surgery, while necessary to treat cancer, can damage the nerves that control erections. is designed to work by restoring healthy blood flow in the penis, potentially helping men recover sexual function after surgery.
Prostate removal is often the most effective treatment for prostate cancer, but it frequently causes erectile dysfunction because the surgery can damage sensitive nerves. Currently, doctors have limited options to help men recover function after surgery. This trial exists to see whether this new treatment can fill that gap and give men better outcomes.
If you enroll, you will be randomly assigned to one of three groups: some men will take a daily oral pill plus apply a placebo gel, others will take an oral placebo plus apply the gel, and a third group will take both the oral medication and the active gel. You will apply the gel or placebo topically to the genital area as instructed. Throughout the study, you'll have follow-up visits where researchers will check your sexual function, examine you for any side effects, and monitor your blood pressure and heart health.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Brazil